Detalhe da pesquisa
1.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Lancet Oncol
; 18(10): 1373-1385, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844499
2.
Improved survival with ipilimumab in patients with metastatic melanoma.
N Engl J Med
; 363(8): 711-23, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525992
3.
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.
Lancet Oncol
; 18(12): e709-e710, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208433
4.
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Invest New Drugs
; 29(3): 489-98, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20082117
5.
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.
Blood Adv
; 4(9): 1917-1926, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380537
6.
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
Clin Cancer Res
; 26(7): 1586-1594, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034072
7.
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Nat Cancer
; 1(12): 1204-1217, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121932
8.
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 35(18): 2028-2036, 2017 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463630
9.
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
J Clin Oncol
; 23(25): 6043-53, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16087944
10.
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
J Clin Oncol
; 33(14): 1609-19, 2015 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25847941
11.
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
J Immunother
; 29(4): 455-63, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799341